Siirry päänavigointiin
Siirry hakuun
Siirry pääsisältöön
Järjestys:
Keyphrases
Colorectal Cancer
86%
Tumor
26%
T Cells
20%
Mismatch Repair
18%
Cell Density
17%
Immune Cell Score
16%
Pulmonary Metastasis
15%
Prognostic Value
13%
Tumor Budding
12%
CD8+
11%
Immune Cell Infiltration
11%
Programmed Death-ligand 1 (PD-L1)
11%
Microsatellite Stable Colorectal Cancer
10%
CD3+
9%
Prognostic Significance
9%
Immune Contexture
9%
Programmed Cell Death Protein 1 (PD-1)
9%
Overall Survival
9%
Rectal Cancer
8%
Prognostic Features
8%
Myeloid Cells
8%
Tumor-infiltrating
8%
Primary Tumor
8%
Cell Infiltration
7%
95% Confidence Interval
7%
Immune Environment
7%
Prognostic Role
7%
Lynch Syndrome
7%
Immunoprofiling
7%
Immunohistochemistry
7%
Multivariable
7%
5-year Survival
7%
Multiplex Analysis
7%
Population-based Study
7%
Tumor Immune Microenvironment
7%
Colorectal Adenocarcinoma
7%
Cancer-specific Survival
6%
Hazard Ratio
6%
Tumor-stroma Ratio
6%
Tumor Cells
6%
Colorectal Cancer Patients
6%
Granulocytes
6%
Histopathological Features
6%
Improved Survival
6%
Microsatellite Instability-high (MSI-H)
5%
Colorectal Carcinoma
5%
Independent Prognostic Factor
5%
Immune Response
5%
Liver Metastasis
5%
Immune Cells
5%
Immunology and Microbiology
Colorectal Carcinoma
100%
T Cell
26%
Immunocompetent Cell
23%
Cell Density
20%
CD3 Antigen
17%
CD8
15%
Mismatch Repair
14%
Tumor Cell
14%
Stroma
12%
Programmed Death-Ligand 1
12%
Cell Infiltration
11%
Immune Cell Infiltration
10%
Myeloid
9%
Cancer Specific Survival
9%
Immune Microenvironment
8%
Immune Response
8%
Cytotoxic T-Cell
7%
Granulocyte
7%
Mucin
7%
Overall Survival
6%
Macrophage
6%
Immunotherapy
5%
Lymphocyte
5%
Medicine and Dentistry
Colorectal Carcinoma
50%
Tumor
15%
Neoplasm
15%
DNA Mismatch Repair
13%
Rectum Cancer
13%
Stroma
11%
Malignant Neoplasm
11%
Metastatic Carcinoma
11%
Immunocompetent Cell
11%
Overall Survival
10%
T Cell
10%
Programmed Death-Ligand 1
8%
Immune Cell Infiltration
8%
CD3 Antigen
8%
Lung Metastasis
7%
Immune Response
7%
Immunohistochemistry
7%
CD8 Antigen
7%
Cell Density
6%
Prognostic Factor
6%
Esophagectomy
5%
Diseases
5%